SCENARIA View Phase 5.0— 510(k) K250370

Substantially Equivalent

Fujifilm Corporation

FDA 510(k) clearance K250370 for SCENARIA View Phase 5.0, Substantially Equivalent on 2025-05-20. Applicant: Fujifilm Corporation.

Clearance details

Applicant: Fujifilm Corporation
Product code: Code JAK
Advisory panel: Radiology
Date received: 2025-02-10
Decision date: 2025-05-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Minato-Ku, JP

Download summary PDF View on FDA.gov ↗

Adverse events under product code JAK

product code JAK

Death: 27
Injury: 571
Malfunction: 779
Total: 1,377

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.